The question was whether maturation was possible
Jayasena and colleagues investigated kisspeptin-54 in 53 women undergoing specialist IVF care. The primary endpoint concerned egg maturation. This 2014 proof-of-concept study did not include a conventional-trigger comparison arm establishing that kisspeptin produced better pregnancy outcomes.
The percentages describe different events
Fertilization and embryo transfer occurred in 49 of 53 participants. Clinical pregnancy occurred in 12 of 53. Ten women subsequently gave birth, including two with twin pregnancies. These results belong to different stages and cannot be substituted for one another. The trial’s small size also limits safety conclusions.
Keep the denominator attached
Consider a hypothetical school report: the percentage submitting an application, the percentage offered a place and the percentage graduating would answer different questions. Fertility research likewise needs the event and denominator beside each percentage. Ask whether a figure counts patients, eggs, embryos or transfers before comparing it with another figure.
Proof of concept is one step in an evidence chain
Showing that an outcome can occur helps justify further testing. Showing that a method improves the chance of that outcome requires an appropriate comparison. Neither statement can silently replace the other. A reader should be able to locate the prespecified primary outcome and distinguish it from later observations.
A historical paper, newly explained
The complete original article was reviewed, including its outcomes and limitations. The publication date remains 2014; this is a new S7 explanation, not a claim of newly published research. The findings do not supply a personal fertility plan or establish equivalence for commercial research material. No administration or treatment instructions are included.